Dysphagia Management Market Size, Share, and Trends 2025 to 2034

The global dysphagia management market size is calculated at USD 5.00 billion in 2025 and is forecasted to reach around USD 8.64 billion by 2034, accelerating at a CAGR of 6.27% from 2025 to 2034. The North America market size surpassed USD 2.26 billion in 2024 and is expanding at a CAGR of 6.37% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Last Updated : June 2025  |  Report Code : 6274  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Dysphagia Management Market 

5.1. COVID-19 Landscape: Dysphagia Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Dysphagia Management Market, By Product Type

8.1. Dysphagia Management Market Revenue and Volume Forecast, by Product Type

8.1.1. Drugs

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Feeding tubes

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Nutritional Solutions

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Others

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Dysphagia Management Market, By Indication

9.1. Dysphagia Management Market Revenue and Volume Forecast, by Indication

9.1.1. Oral Dysphagia

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Oropharyngeal Dysphagia

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Esophageal Dysphagia

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Dysphagia Management Market, By Age Group

10.1. Dysphagia Management Market Revenue and Volume Forecast, by Age Group

10.1.1. Children

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Adults

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Geriatric

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Dysphagia Management Market, By End-User 

11.1. Dysphagia Management Market Revenue and Volume Forecast, by End-User

11.1.1. Hospitals and Ambulatory Surgical Centers

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Homecare Settings

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Long-term Care Facilities

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Outpatient Clinics

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Dysphagia Management Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type  

12.1.2. Market Revenue and Volume Forecast, by Indication

12.1.3. Market Revenue and Volume Forecast, by Age Group

12.1.4. Market Revenue and Volume Forecast, by End-User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type  

12.1.5.2. Market Revenue and Volume Forecast, by Indication

12.1.5.3. Market Revenue and Volume Forecast, by Age Group

12.1.5.4. Market Revenue and Volume Forecast, by End-User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type  

12.1.6.2. Market Revenue and Volume Forecast, by Indication

12.1.6.3. Market Revenue and Volume Forecast, by Age Group

12.1.6.4. Market Revenue and Volume Forecast, by End-User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type  

12.2.2. Market Revenue and Volume Forecast, by Indication

12.2.3. Market Revenue and Volume Forecast, by Age Group

12.2.4. Market Revenue and Volume Forecast, by End-User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type  

12.2.5.2. Market Revenue and Volume Forecast, by Indication

12.2.5.3. Market Revenue and Volume Forecast, by Age Group

12.2.5.4. Market Revenue and Volume Forecast, by End-User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type  

12.2.6.2. Market Revenue and Volume Forecast, by Indication

12.2.6.3. Market Revenue and Volume Forecast, by Age Group

12.2.6.4. Market Revenue and Volume Forecast, by End-User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type  

12.2.7.2. Market Revenue and Volume Forecast, by Indication

12.2.7.3. Market Revenue and Volume Forecast, by Age Group

12.2.7.4. Market Revenue and Volume Forecast, by End-User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type  

12.2.8.2. Market Revenue and Volume Forecast, by Indication

12.2.8.3. Market Revenue and Volume Forecast, by Age Group

12.2.8.4. Market Revenue and Volume Forecast, by End-User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type  

12.3.2. Market Revenue and Volume Forecast, by Indication

12.3.3. Market Revenue and Volume Forecast, by Age Group

12.3.4. Market Revenue and Volume Forecast, by End-User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type  

12.3.5.2. Market Revenue and Volume Forecast, by Indication

12.3.5.3. Market Revenue and Volume Forecast, by Age Group

12.3.5.4. Market Revenue and Volume Forecast, by End-User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type  

12.3.6.2. Market Revenue and Volume Forecast, by Indication

12.3.6.3. Market Revenue and Volume Forecast, by Age Group

12.3.6.4. Market Revenue and Volume Forecast, by End-User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type  

12.3.7.2. Market Revenue and Volume Forecast, by Indication

12.3.7.3. Market Revenue and Volume Forecast, by Age Group

12.3.7.4. Market Revenue and Volume Forecast, by End-User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type  

12.3.8.2. Market Revenue and Volume Forecast, by Indication

12.3.8.3. Market Revenue and Volume Forecast, by Age Group

12.3.8.4. Market Revenue and Volume Forecast, by End-User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type  

12.4.2. Market Revenue and Volume Forecast, by Indication

12.4.3. Market Revenue and Volume Forecast, by Age Group

12.4.4. Market Revenue and Volume Forecast, by End-User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type  

12.4.5.2. Market Revenue and Volume Forecast, by Indication

12.4.5.3. Market Revenue and Volume Forecast, by Age Group

12.4.5.4. Market Revenue and Volume Forecast, by End-User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type  

12.4.6.2. Market Revenue and Volume Forecast, by Indication

12.4.6.3. Market Revenue and Volume Forecast, by Age Group

12.4.6.4. Market Revenue and Volume Forecast, by End-User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type  

12.4.7.2. Market Revenue and Volume Forecast, by Indication

12.4.7.3. Market Revenue and Volume Forecast, by Age Group

12.4.7.4. Market Revenue and Volume Forecast, by End-User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type  

12.4.8.2. Market Revenue and Volume Forecast, by Indication

12.4.8.3. Market Revenue and Volume Forecast, by Age Group

12.4.8.4. Market Revenue and Volume Forecast, by End-User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type  

12.5.2. Market Revenue and Volume Forecast, by Indication

12.5.3. Market Revenue and Volume Forecast, by Age Group

12.5.4. Market Revenue and Volume Forecast, by End-User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type  

12.5.5.2. Market Revenue and Volume Forecast, by Indication

12.5.5.3. Market Revenue and Volume Forecast, by Age Group

12.5.5.4. Market Revenue and Volume Forecast, by End-User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type  

12.5.6.2. Market Revenue and Volume Forecast, by Indication

12.5.6.3. Market Revenue and Volume Forecast, by Age Group

12.5.6.4. Market Revenue and Volume Forecast, by End-User

Chapter 13. Company Profiles

13.1. AstraZeneca

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Bayer AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Pfizer, Inc

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Takeda Pharmaceutical Company Limited

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Dr Reddy's Laboratories Ltd.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Narang Medical Limited

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Advin Health Care

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Cardinal

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Abbott

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global dysphagia management market is expected to increase from USD 4.71 billion in 2024 to USD 8.64 billion by 2034.

The dysphagia management market is expected to grow at a compound annual growth rate (CAGR) of around 6.27% from 2025 to 2034.

The major players in the dysphagia management market include AstraZeneca, Bayer AG, Pfizer, Inc, Takeda Pharmaceutical Company Limited , Abbott, Dr Reddy's Laboratories Ltd., Narang Medical Limited, Advin Health Care, and Cardinal.

The driving factors of the dysphagia management market are the development of smart feeding tubes, thickening agents, and portable diagnostic tools improves treatment outcomes.

North America region will lead the global dysphagia management market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client